Lys173 Arg and -344T/C variants of CYP11B2 in Japanese patients with low-renin hypertension

Hypertension

Volumn 35, Issue 3, 2000, Pages 699-703

  Komiya, Ichiro ^a   Yamada, Takashi ^b   Takara, Masaki ^a   Asawa, Takayuki ^a   Shimabukuro, Michio ^a   Nishimori, Takeshi ^b   Takasu, Nobuyuki ^a  

^a UNIVERSITY OF THE RYUKYUS SCHOOL OF MEDICINE   (Japan)

^b TOKYO UNIVERSITY OF SCIENCE   (Japan)

Author keywords

Aldosterone; Cytochrome P 450; Hypertension, essential; Polymorphism; Renin angiotensin system

Indexed keywords

ALDOSTERONE; CYTOCHROME P450 ISOENZYME; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN; ALDOSTERONE SYNTHASE; ARGININE; LYSINE;

ADULT; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; FEMALE; GENE DELETION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; AGED; ALLELE; BLOOD; GENE EXPRESSION REGULATION; GENETIC MARKER; GENETICS; MIDDLE AGED; NUCLEOTIDE SEQUENCE; PHYSIOLOGY; PROMOTER REGION; RENOVASCULAR HYPERTENSION;

ADULT; AGED; ALDOSTERONE; ALDOSTERONE SYNTHASE; ALLELES; ARGININE; DNA MUTATIONAL ANALYSIS; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENETIC MARKERS; HUMANS; HYPERTENSION, RENAL; JAPAN; LYSINE; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 0033621809     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.3.699     Document Type: Article

References (26)

1. Rigat B. Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest. 1990;86:1343-1346.
2. Bonnardeaux A, Davies E, Jeunemaitre X, Féry I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F. Angiotensin II type I receptor gene polymorphisms in human essential hypertension. Hypertension. 1994;24:63-69.
3. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM, Corvol P. Molecular basis of human hypertension: role of angiotensinogen. Cell. 1992;71:169-180.
4. Caulfield M, Lavender P, Farral M, Munroe P, Lawson M, Turner P, Clark AJL. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med. 1994;330:1629-1633.
5. Komiya I, Yamada T, Takasu N, Aizawa T, Niwa A, Maruyama Y, Ogawa A. Inappropriate elevation of the aldosterone/plasma renin activity ratio in hypertensive patients with increases of 11-deoxycorticosterone and 18-hydroxy-11-deoxycorticosterone: a subtype of essential hypertension? Cardiology. 1991;78:99-110.
6. Komiya I, Yamada T, Takasu N, Asawa T. Akamine H. Yagi N, Nagasawa Y, Ohtsuka H, Miyahara Y, Sakai H, Sato A, Aizawa T. An abnormal sodium metabolism in Japanese patients with essential hypertension, judged by serum sodium distribution, renal function and the renin-aldosterone system. J Hypertens. 1997;15:65-72.
7. Guyton AC. Blood pressure control-special role of the kidneys and body fluids. Science. 1991;252:1813-1816.
8. Zhang G, Miller WL. The human genome contains only two CYP11B2 (P450c11) genes. J Clin Endocrinol Metab. 1996;81:3254-3256.
9. Fardella CE, Miller WL. Molecular biology of mineralocorticoid metabolism. Annu Rev Nutr. 1996;16:443-470.
10. White PC, Curnow KM, Pascoe L. Disorders of steroid 11 β-hydroxylase isozymes. Endocr Rev. 1994;15:421-438.
11. Cover CM, Wang JM, Lezin ES, Kurtz TW, Mellon SH. Molecular variants in the P450c11AS gene as determinants of aldosterone synthase activity in the Dahl rat model of hypertension. J Biol Chem. 1995;270: 16555-16560.
12. Fardella CE, Rodriguez H, Montero J, Zhang G, Vignolo P, Rojas A, Villarroel L, Miller WL. Genetic variation in P450c11AS in Chilean patients with low renin hypertension. J Clin Endocrinol Metab. 1996;81: 4347-4351.
13. Davies E, Holloway CD, Ingram MC, Inglis GC, Friel EC, Morrison C, Anderson NH, Fraser R, Connell JMC. Aldosterone excretion rate and blood pressure in essential hypertension are related to polymorphic differences in the aldosterone synthase gene CYP11B2. Hypertension. 1999; 33:703-707.
14. Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyama T. A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity: results in hypertensive patients. Arch Intern Med. 1981;141:1589-1593.
15. Hautanena A, Lankinen L, Kupari M, Jänne OA, Adlercreutz H, Nikkilä H, White PC. Associations between aldosterone synthase gene polymorphism and the adrenocortical function in males. J Intern Med. 1998; 244:11-18.
16. Tiret L, Rigat B. Visvikis S, Breda C, Corvol P, Combien F, Soubrier F. Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet. 1992;51:197-205.
17. Lindpaintner K, Pfeffer MA. Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, Buring J, Hennekens CH. A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med. 1995;332:706-711.
18. Brand E, Chatelain N, Mulatero P, Féry I, Curnow K, Jeunemaitre X, Corvol P, Pascoe L, Soubrier F. Structural analysis and evaluation of the aldosterone synthase gene in hypertension. Hypertension. 1998;32: 198-204.
19. Pojaga L, Gautier S, Blanc H, Guyene TT, Poirier O, Cambien F, Benetos A, Genetic determination of plasma aldosterone levels in essential hypertension. Am J Hypertens. 1998;11:856-860.
20. Lins PE, Adamson U. Plasma aldosterone-plasma renin activity ratio: a simple test to identify patients with primary aldosteronism. Acta Endocrinol (Copenh). 1986;113:564-569.
21. McKenna TJ, Sequeira SJ, Heffernan A, Chambers J, Cunningham S. Diagnosis under random conditions of all disorders of the renin-angiotensin-aldosterone axis, including primary hyperaldosteronism. J Clin Endocrinol Metab. 1991;73:952-957.
22. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC. High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol. 1994;21:315-318.
23. Cambien F, Costerousse O, Tiret L, Poirier O, Lecerf L, Gonzales MF, Evans A, Arveiler D, Cambou JP, Luc G, Rakotovao R, Ducimetiere P, Soubrier F, Alhenc-Gelas F. Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation. 1994;90:669-676.
24. Higashimori K, Zhao Y, Higaki J, Kamitani A, Katsuya T, Nakura J, Miki T, Mikami H, Ogihara T. Association analysis of a polymorphism of the angiotensin converting enzyme gene with essential hypertension in the Japanese population. Biochem Biophys Res Commun. 1993;191: 399-404.
25. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM. Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet. 1992;1:72-75.
26. Krege JH, Kim HS, Moyer JS, Jennette JC, Peng L, Hiller SK, Smithies O. Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension. 1997;29:150-157.